Cisplatin Nanoparticle Composition (Oral Administration)

ID: VR-01

Cisplatin is a chemotherapy drug used to treat a variety of cancers, including testicular, lung, bladder, cervical, and ovarian cancers. It’s an alkylating agent that contains platinum, which damages DNA and stops cells from dividing. Cisplatin Market size was valued at USD 14.2 Billion in 2023 and is projected to reach USD 25.6 Billion by 2031, growing at a CAGR of 8.23% during the forecast period 2024-2031.[1]

  • Patent Status: Granted in India and Filed in the US
  • Options: The inventor is open to explore Patent Licensing, Assignment or Joint Venture
  • Unique features: Nano particle, High Bioavailability, Oral administration
  • Stage: Commercially used
  • Ask price: To be discussed

Contact us now!

Subscribe to our newsletter!

Get alerts on new posts and exclusive updates — directly to your inbox.

We don’t spam! Read our privacy policy for more info.

You may also like...

Popular Posts